For Research Use Only. Not for human or veterinary use.

Siamycin I (CAS: 164802-68-0)

Product ID: BLK-0900
Structure
Chemical structure of Siamycin I (CAS 164802-68-0, molecular formula C97H131N23O26S4)
Chemical structure of Siamycin I (CAS 164802-68-0)
CAS164802-68-0
Molecular FormulaC97H131N23O26S4
Molecular Weight2163.52
Price1mg: USD 190.00 / 5mg: - / 25mg: -
Storage-20°C
Solubility1mg/ml ethanol, methanol, DMSO
Purity>95% [View LC/UV Data]
LC/UVRepresentative LC/UV chromatogram under typical analytical conditions (C18 column; mobile phase: 5–100% ACN / H2O (0.05% H3PO4), linear gradient 20 min; flow rate: 0.2 mL/min; detection: 210 nm).
NMR Data1H NMR (CD3OD, 500 MHz) [View] [Full page]
NMR Spectral DataRepresentative 1H NMR (CD3OD, 500 MHz) spectrum confirming the structure of Siamycin I.
Representative 13C NMR (CD3OD, 125 MHz) spectrum supporting structural assignment of Siamycin I.
Source OrganismStreptomyces sp.
SummarySiamycin I is a 21-residue lasso peptide that inhibits HIV fusion and targets lipid II.
Details
Browse Related
MechanismHIV fusion inhibitor
Primary TargetHIV-1 gp160; Lipid II; Histidine kinase FsrC; Histidine kinase VanS
PathwayViral membrane fusion pathway; Peptidoglycan biosynthesis; Two-component signaling pathway
Chemical ClassLasso peptide (RiPP)
Discovery Year1994
Keywords
References
  1. Frèchet et al., Biochemistry, 1994 (solution structure; amphipathic lasso peptide)
    DOI: 10.1007/BF00211754
  2. Romeo et al., Antimicrob Agents Chemother, 1996 (HIV fusion inhibition; gp160 resistance mapping)
    DOI: 10.1128/AAC.40.1.133
  3. Hegemann et al., ACS Chem Biol, 2019 (lipid II targeting; cell wall biosynthesis inhibition)
  4. Berger et al., iScience, 2025 (histidine kinase FsrC/VanS inhibition; anti-virulence; vancomycin restoration)
Request pricing, availability, or bulk supply information for this compound.
Get a QuoteGeneral Inquiry
Documents
← Back to Catalog